Biblio Discovery — Demo Discovery Service

85 results for "Javaheri, Ali"

Showing 81–85 · 0.85 seconds · RSS

  1. Journal Article Full text

    Effect of Sodium Glucose Cotransporter 2 Inhibitors on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Pragmatic, Multicentre, Open Label, Randomized Controlled Trial

    Kosiborod, Mikhail N.; Windsor, Sheryl L.; Vardeny, Orly et al.

    Lancet Diabetes Endocrinol · 2024 · English · PubMed Central

    BACKGROUND: Patients hospitalized for Coronavirus disease 2019 (COVID-19) are at risk for multiorgan failure and death. Sodium glucose cotransporter 2 (SGLT2) inhibitors provide cardiovascular and kidney protection in patients with cardiometabolic conditions and may provide organ protection during…

  2. Journal Article Full text

    Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

    Kosiborod, Mikhail N; Esterline, Russell; Furtado, Remo H M et al.

    Lancet Diabetes Endocrinol · 2021 · English · PubMed Central

    BACKGROUND: COVID-19 can lead to multiorgan failure. Dapagliflozin, a SGLT2 inhibitor, has significant protective benefits for the heart and kidney. We aimed to see whether this agent might provide organ protection in patients with COVID-19 by affecting processes dysregulated during acute illness…

  3. Journal Article Full text

    Deficiency Of the Deubiquitinase, UCHL1, Attenuates Pulmonary Arterial Hypertension

    Tang, Haiyang; Gupta, Akash; Morrisroe, Seth A. et al.

    Circulation · 2024 · English · PubMed Central

    RATIONALE: While the ubiquitin-proteasome system regulates protein degradation and the development of pulmonary arterial hypertension (PAH), limited is known about the role of deubiquitinating enzymes (DUBs) in this process. Ubiquitin carboxyl-terminal esterase-L1 (UCHL1), a deubiquitinase, has…

  4. Journal Article Full text

    Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19

    Self, Wesley H.; Shotwell, Matthew S.; Gibbs, Kevin W. et al.

    JAMA · 2023 · English · PubMed Central

    IMPORTANCE: Preclinical models suggest dysregulation of the renin-angiotensin system (RAS) caused by SARS-CoV-2 infection may increase the relative activity of angiotensin II compared with angiotensin (1-7) and may be an important contributor to COVID-19 pathophysiology. OBJECTIVE: To evaluate the…

  5. Journal Article Full text

    Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia

    Collins, Sean P.; Shotwell, Matthew S.; Strich, Jeffrey R. et al.

    JAMA Netw Open · 2024 · English · PubMed Central

    IMPORTANCE: Fostamatinib, a spleen tyrosine kinase inhibitor, has been reported to improve outcomes of COVID-19. OBJECTIVE: To evaluate the efficacy and safety of fostamatinib in adults hospitalized with COVID-19 and hypoxemia. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, phase 3…